Dimensional Fund Advisors’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,371
Closed -$107 3503
2022
Q4
$107 Hold
15,371
﹤0.01% 3320
2022
Q3
$56K Sell
15,371
-29,566
-66% -$97.9K ﹤0.01% 3393
2022
Q2
$146K Hold
44,937
﹤0.01% 3281
2022
Q1
$90K Sell
44,937
-2,952
-6% -$7.23K ﹤0.01% 3406
2021
Q4
$150K Sell
47,889
-5,159
-10% -$21.4K ﹤0.01% 3387
2021
Q3
$260K Sell
53,048
-75,235
-59% -$456K ﹤0.01% 3307
2021
Q2
$854K Sell
128,283
-34,504
-21% -$225K ﹤0.01% 3061
2021
Q1
$913K Buy
162,787
+150,305
+1,204% +$1.44M ﹤0.01% 3032
2020
Q4
$98K Buy
+12,482
New +$105K ﹤0.01% 3278
2020
Q2
Sell
-14,858
Closed -$139K 3362
2020
Q1
$139K Buy
+14,858
New +$127K ﹤0.01% 3241

Other funds holding WVE

Dimensional Fund Advisors's WVE Position: Q1 2023 in Review

Dimensional Fund Advisors sold out of Wave Life Sciences (WVE) in Q1 2023, closing a stake of 15,371 shares — an estimated $107 sold.

Dimensional Fund Advisors first reported a position in WVE in Q1 2020 and held it in 10 quarters. The position peaked at $913K in Q1 2021. 72 funds tracked by Wall St. Rank hold WVE as of Q1 2023.

  • Dimensional Fund Advisors reported no remaining Wave Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 15,371 Wave Life Sciences shares in Q1 2023, an estimated $107.
  • Dimensional Fund Advisors first reported a position in Wave Life Sciences in Q1 2020 and held it in 10 quarters.
  • Dimensional Fund Advisors's Wave Life Sciences position peaked at $913K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2023.

Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.